Related Experiment Video
Updated: Jan 7, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Systematic Review and Meta-Analysis on Heavy Metals and Trace Elements in Mild Cognitive Impairment
Yaxin Dong1, Lu Ren1, TianRan Tang2
1Shanghai University of Medicine & Health Sciences, No. 279, Zhouzhu Highway, Pudong New Area, Shanghai, 201318, China.
Abstract:
Mild cognitive impairment (MCI) represents a prodromal stage of various neurodegenerative diseases. However, heterogeneity persists regarding heavy metal and trace element levels in MCI patients. PubMed, Web of Science, and Chinese academic databases were systematically searched from 2000 to the present, and 43 case-control/cross-sectional studies on the levels of heavy metals and trace elements in MCI and healthy controls were included, and the standardized mean difference (SMD) of 12 elements (Al, As, Cd, Pb, Cu, Se, Zn, etc.) was evaluated by using a random-effects model. A total of 16,743 samples were included. Al (SMD: 0.73, 95%CI: 0.31-1.14), As (SMD: 0.19, 95%CI: 0.03-0.35), Cd (SMD: 0.91, 95%CI: 0.43-1.38), Cu (SMD: 0.69, 95%CI. 0.27-1.10), Pb (SMD: 0.77, 95%CI: 0.30-1.24) were significantly elevated in the MCI patients, while Se (SMD: -0.28, 95%CI: -0.56-0.01) and Zn (SMD: -0.77, 95%CI: -1.22-0.33) were significantly lower. No statistical differences were observed for the remaining elements (Fe, Mg, etc.). Levels of specific heavy metals and trace elements in MCI patients differ from those in healthy controls. Monitoring and modulating these element levels may provide novel targets for early intervention strategies.
Insights
Levels of certain heavy metals and trace elements differ in individuals with mild cognitive impairment (MCI). Monitoring these elements may offer new strategies for early intervention in neurodegenerative diseases.
Area of Science:
- Neuroscience
- Environmental Health
- Biochemistry
Background:
- Mild cognitive impairment (MCI) is an early stage of neurodegenerative diseases.
- Significant heterogeneity exists in heavy metal and trace element levels among MCI patients.
- Understanding these elemental differences is crucial for early diagnosis and intervention.
Purpose of the Study:
- To systematically review and meta-analyze studies on heavy metal and trace element levels in MCI patients compared to healthy controls.
- To identify specific elements with altered concentrations in MCI.
- To explore potential diagnostic or therapeutic targets based on elemental profiles.
Main Methods:
- Systematic literature search of PubMed, Web of Science, and Chinese academic databases (2000-present).
- Inclusion of 43 case-control/cross-sectional studies involving 16,743 samples.
- Meta-analysis using a random-effects model to calculate standardized mean differences (SMD) for 12 elements.
Main Results:
- Elevated levels of Aluminum (Al), Arsenic (As), Cadmium (Cd), Copper (Cu), and Lead (Pb) were observed in MCI patients.
- Significantly lower levels of Selenium (Se) and Zinc (Zn) were found in MCI patients.
- No significant differences were noted for Iron (Fe) and Magnesium (Mg), among others.
Conclusions:
- Specific heavy metal and trace element profiles are associated with mild cognitive impairment.
- Altered levels of Al, As, Cd, Cu, Pb, Se, and Zn suggest their potential role in MCI pathogenesis.
- Monitoring and modulating these element levels could represent novel targets for early intervention strategies in neurodegenerative diseases.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Dementia
The progression of dementia is generally gradual....
The Periodic Table and Organismal Elements
Periodic Table Provides Information...

